Connect with us

Cannabis News

Coca Prohibition Is More Harmful Than The Plant Itself, World Health Organization Review Concludes

Published

7 months ago

on

“Research records, however, documents strongly documented public health damage related to position strategies in all scales”.

Mattha Busby, filter

The consumption of coca-leaf during the Andes does not have a significant risk, but the official CCO control strategies are linked according to a review of “Public Health Damage”.

Filter It was a previous copy of the report distribute Expert Commission on Drug Addiction (ECDD).

Coca, a stimulating and medicinal component of the cocaine component, banned by UN 1964 His researchers claimed Chewing the coca leaf is “definitively harmful” and “cause of racial degeneration of many population groups.” A who is also the paper as well describe Using a rich calcium plant “as a social disease”.

Despite the production of location leaves, during decades, Peru, Bolivia and Ecuador, during the drug war, indigenous communities remain in deep spiritual values ​​- in the height of all time in Colombia.

“Reviewed research for this report does not reveal evidence caused by the damage to public health related to coca leaves” to states ECDD’s extensive scientific review of commissioned. “Research records, however, documents strongly documented public health damage related to position strategies in all scales”.

The review is currently in draft mode and is subject to copying. It was commissioned among the growing international citation Koke, to finish the prohibition of Coca Filter previously reported.

In October, an international group of independent experts contracted by ECDD, and should be taken into account the most limited situation to change in the Coca’s current program. The meaning is that researchers understand the sources of leaves that understand the impossible.

One of the recommendations would be presented in December to the Narkotic Drug Commission, with a rotating member of 53 National Member States. In March 2026, the CND will vote for any recommendation. Coca may change or disable, which would have great ramifications, finish his use of criminalization and potentially providing an important economic economy in Latin American producers.

“We haven’t been a recommendation for the Commission, but it will be difficult to recommend how they could recommend KOKA Calendar,” Steve Rolls, Transform Drug Policy Foundation, charity campaign, drug legal regulation Filter.

“It’s quite likely to recommend (ECDD) really desecute, that is, they expect a lot of people in Colombia, Bolivia and civil society,” he continued. “Leaving the Coca in any schedule does not implicitly criminalizes millions of people who use it traditionally.”

However, those who make a scholarship recommendation, Rolles expects the CND currently The United Kingdom, Saudi Arabia and China counts among members, to vote. “The banners would be around forbiders and any desecrants would be forbidden because they were so paranoids around the cocaine,” he said.

In February, President Colombia gave the President Gustavo Petro Legalization of cocaine, described “worse than whiskey”. The external government of Bolivia’s left and indigenous government is called “Coca leaf colonization”, “but it will not be very difficult that the right government will put reform.

Whosely-based pesticides based on the rounded papers showed exposure, with a safe carcinogene, the number of medical consultations in the coke crop crop is “increased by the number of medical communities and breathing.”

He added that another study was eligible to increase coca farmers with increasing production of production, “increasing the exposure to the subsequent coca-plots” increasing exposure to chemicals. “

In the 1990s Coca farmers destroyed their crops and even when they were arrested and prosecuted for traditional uses. “Chronic exposure to agro-chemical products increases health risks related to neurological damage, bodies failure and reproductive health problems,” the papers said. “Pesticides and other farmers worked in the planned crop can cause security profiles and health profiles and health risks related to the use of the workshop.”

Indigenous spilled areas also complained “Flu symptoms, including nausea, dizziness, intervals, diarrhea, depending on the 2001 Report of the 2001 Institute”, according to the 2001 Republic of the Institute, Progressive thought.

“At least it seems that the discussion will encourage science and evidence,” Ricardo Sobern, Devida, the former president of the official drug control committee, said, said Filter. “Latin American states, as well as 53 members of CND, I must understand that the desktop will strengthen the gang fighting.”

The director of the Martin Jelsma, the Transnational Institute, said the review report “clearly” establishes that there is no harm or dependency of public health related to Coca leaf. “In terms of use of medicines, the evidence is still preliminary, but the potential is” great interest “to establish efficiency and safety for future development in human medicine”, ” Filter. “These basic consequences remove the original justification at the I.

The only reason to keep the coca leaf will remain in cocaine cocaine, “and the report indicated that the cocaine can be created from the Coca leaf” solvent extraction “than the process of” conversion “that assumes the chemical transformation of the molecule.”

The report refers to Koka’s cultural meaning, as well as the use of herbal medicine, but the violation of indigenous and human rights rights “intentionally avoided the impact of current controls,” he said.

The revision does not have the result of the healthcare consequences of the enforcement strategy of eradication of coca and eradicate traffic supply, Many experts say fuel violence.

Composing issues created as a result of prohibition by Coca, conservation campaigns said to eradicate the efforts that often comply with the growers to be further from the inspections of law enforcement.

The report is to use food in Coca, drinks such as energy tonic and beer, they are also increasing cosmetics that claim anti-aging properties and fabrics.

Although the report is noticed by public health damage associated with the leaf, the report has said “Undercoming literature on botanical, historical and cultural leaves, which evaluate their clinical effects are properly designed.” However, he said, “There is no evidence … a serious coca-leaf of humans.”

This article was originally published FilterUse of drug use, drug policy and human rights to reduce the damage to the online magazine through a lens. Continue filter Blues, X or Ocuookand Sign up for his newsletter.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Related Topics:
Continue Reading

Cannabis News

Klasmann-Deilmann announces management changes

Published

3 hours ago

on

April 29, 2026

By











After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.

© Klasmann-Deilmann Benelux

Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.

With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.

For more information:
Klasmann-Deilmann GmbH
(email protected)
www.klasmann-deilmann.com



Publication date:













Continue Reading

Cannabis News

Congressional Amendments To Delay Or Speed Up Federal Hemp THC Product Ban Won’t Get Votes

Published

3 hours ago

on

April 29, 2026

By

Congressional amendments to both delaying the scheduled federal recriminalization of hemp THC products for another year or to speed up implementation will not be considered on the House floor this week.

Rep. James Comer (R-KY) introduced the delay proposal as an amendment to the Farm Bill, while Rep. Mary Miller (R-IL) introduced an expedited approach. Neither will move forward, however, with Comer withdrawing his measure and the House Rules Committee failing to vote on Miller’s.

Hemp derivatives containing less than 0.3 percent delta-9 THC by weight of the drug were made federally legal under the 2018 Farm Bill signed by President Donald Trump in his first term. But late last year, Trump signed new legislation containing provisions that will redefine hemp so that only products with a total of 0.4 milligrams of THC per container will be legal starting Nov. 12.

Comer’s amendment, sponsored by Reps. Kelly Morrison (D-MN), Ilhan Omar (D-MN) and Morgan Griffith (R-VA), would have delayed the ban until November 2027.

According to Miller’s proposal, however, the ban will begin the day the new Farm Bill takes effect. However, it is unclear based on progress in Congress whether the large-scale farming legislation will actually become law, and the legislation could not pass until after the current recriminalization date.

Comer told the panel at Monday’s meeting that his amendment would “protect American farmers” and “help the hemp industry and the thousands of jobs that use and rely on these products.”

“It is clear that Congress needs more time to pass legislation that protects jobs, eliminates bad actors, standardizes labeling and requires third-party testing,” he said. “My amendment would give Congress another year, until November 2027, to develop this solution.”

It is not clear why he decided to remove it from the annex to the proposal Farm BillAlso known as the Farm, Food, and National Security Act of 2026, or HR 7567.




Griffith, a member of the Rules Committee who sponsored Comer’s amendment, noted that there are “a lot of hemp products from overseas that don’t have third-party testing” on the market, “frankly all kinds of junk.”

He said the real solution is for the Food and Drug Administration (FDA) to regulate the products, citing a separate bill he has introduced on the issue, but argued that “we have to have time to adjust,” which he said would provide the delay amendment.

Meanwhile, Rep. Andy Barr (R-KY) also introduced an amendment to the bill that, according to the sponsor’s summary, “changes the definition of hemp to protect the legal hemp market, creating a regulatory framework that protects children, bans synthetics, and ensures that products on the market are of American origin.”

The congressman later withdrew the proposal for undisclosed reasons.

However, he recently received a letter White House officials commented on pending legislation to create a regulatory framework for hemp.

Last week, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Barr, who is helping lead efforts to establish regulations for the plant as an alternative to prohibition.

“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.

“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”

The annex to the administration’s proposed legislative text has not been released publicly, and the White House and Barr’s office did not immediately respond to Marihuana Moment’s request for more details.

It’s not clear from the text of the letter whether the White House was proactively sending legislative proposals to the lawmaker or whether they were responding to something sent by his office, though two cannabis industry sources suggested to Marihuana Moment that Barr was sending the language to the administration, and then providing technical feedback.

Trump this week It inspired lawmakers in Congress to take action to change the currently planned hemp banand suggested that this threatens to federally recriminalize full-spectrum CBD products.

“I’m calling on Congress to update the Act so Americans can continue to have access to the full-spectrum CBD products they trust and support, while maintaining Congress’ intent to restrict the sale of products that pose health risks,” the president said in a Truth Social message Thursday, the same day his administration announced it is moving forward to re-regulate marijuana.

“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”

Rep. Jim Baird (R-IN) had it introduced the hemp ban delay amendment before the House Agriculture Committee when it took up the Farm Bill last month, but the president of that panel determined that the proposal was not in line with the legislation.

The Farm Bill passed by the previous committee includes provisions to help the hemp industry and farmers who grow cannabis for industrial purposes, such as fiber and grain. For example, the legislation would amend statutes related to states and tribes developing regulatory plans for industrial hemp production, including policies on testing, sampling, background checks and record keeping.

Other bipartisan hemp reform bills are pending in Congress.

This month, for example, it was introduced by Senators Rand Paul (R-KY), Amy Klobuchar (D-MN) and Joni Ernst (R-IA). The Hemp Safety Enforcement Act, which would give states the option of federal recriminalization of THC hemp products. it will be established this year.

Ernst withdrew his name, however, as a sponsor of the legislation. His office did not respond to Marihuana Moment’s request for clarification on the move.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

The US Department of Agriculture published this month shows that US farmers grow $3 billion in hemp crops by 2025— 64% increase compared to the previous year.

Meanwhile, this month the Trump administration launched a new initiative Cover up to $500 of hemp-derived products annually for eligible Medicare patients. The program being implemented by the Centers for Medicare and Medicaid Services (CMS) focuses largely on CBD, but also allows a certain amount of THC in products.

Anti-marijuana organizations filed a lawsuit against the Medicare hemp coverage policyand Health and Human Services attorneys. Robert F. Kennedy Jr. and CMS Director Mehmet Oz recently He submitted a letter requesting the filing of the case.

Meanwhile, the White House Management and Budget Office has held a series of meetings a Food and Drug Administration (FDA) CBD product enforcement policy.

The FDA also issued guidance making it clear that it does not intend to interfere Establish a Medicare coverage plan for hemp-derived products.

CMS finalized a rule that will be adopted separately Coverage of certain hemp products, primarily as specialized health-related benefits, through Medicare Advantage the plans

As hemp products become more popular among consumers, some big brands are trying to get in on the action.

The main retailer Target, for example, is expanding its involvement in the hemp-derived THC beverage market. Last year, the company began a pilot program in 10 stores in Minnesota that sell cannabis drinks. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

NC lawmakers revisit marijuana policy following reclassification

Published

1 day ago

on

April 28, 2026

By











North Carolina lawmakers say they’re fueling debate over the state’s marijuana laws — a move by the Trump administration to reclassify it as a less dangerous drug.

Across the country, a set of laws and enforcements regulate marijuana. The drug is illegal under federal law, but dozens of US states have legalized it. And almost all states have legalized medical marijuana prescriptions for certain ailments. North Carolina is among the remaining states to resist any form of legalization. Republican politicians in North Carolina have resisted passing any bills to legalize or decriminalize marijuana, despite public opinion polls showing broad public support for such changes.

Senate President Phil Berger said he expects his chamber to revisit efforts to legalize medical marijuana this week. “We will have a conversation within our caucus if they are interested in whether we do something,” Berger told reporters Tuesday.

The recent actions of Republican President Donald Trump may add a new dimension to these conversations. Trump’s acting attorney general on Thursday signed the drug classification as a less dangerous and less strictly regulated drug than marijuana. Federal law does not legalize marijuana for medical or recreational use.

Read more at WRAL News










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media